Laden...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas 03/28/2018 12:00 PM EDTProgression-free survival is the length of time patients lived before their disease worsened. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. |
Laden...
Laden...
© 2024